To determine whether the attenuated CD154 expression of T cells after TNF-α blockade was secondary to decreased disease activity or due to primary inhibitory effect of TNF-α blockade treatment on T cells, purified CD4+ T cells from RA patients were stimulated with ionomycin and PMA for 6 hours. The gene discussed is CD4; the disease is rheumatoid arthritis.